Is there a minimum number of lymph nodes that should be examined after surgical resection of colorectal cancer?;¿Existe un número mínimo de ganglios linfáticos que se debe analizar en la cirugía del cáncer colorectal?

Cirugia Espanola

Volumn 83, Issue 3, 2008, Pages 108-117

  Martínez Ramos, David ^a   Escrig Sos, Javier ^a   Miralles Tena, Juan Manuel ^a   Rivadulla Serrano, Isabel ^a   Salvador Sanchis, José Luis ^a  

^a HOSPITAL GENERAL DE CASTELLÓN   (Spain)

Author keywords

Cancer; Colon; Colorectal; Lymph nodes; Rectum; Staging

Indexed keywords

EID: 40949088661     PISSN: 0009739X     EISSN: 1578147X     Source Type: Journal    
DOI: 10.1016/S0009-739X(08)70524-4     Document Type: Review

References (84)

1. Ministerio de Sanidad y Consumo, La situación del cáncer en España, Madrid: Cian, Proyectos y Producciones Editoriales; 2001.
2. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe 2006, Ann Oncol, 2007;18:581-92.
3. Cohen AM, Tremiterra S, Candela F, Thaler HT, Sigurdson ER, Prognosis of node-positive colon cancer. Cancer. 1991;67:1859-61.
4. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists consensus statement, Arch Pathol Lab Med. 2000;124:979-94.
5. Ratto C, Sofo L, Ippoliti M, Merico M, Bossola M, Vecchio FM, et al. Accurate lymph-node detection in colorectal specimens resected for cancer is prognostic significance, Dis Colon Rectum. 1999;42:143-58.
6. a ed, New York: Wiley-Liss; 2002.
7. Dukes CE, The classification of cancer of the rectum. J Pathol Bacteriol. 1932;35:323-32.
8. Cohen AM, Kelsen D, Saltz L, Minsky BD, Nelson H, Farouk R, et al. Adjuvant therapy for colorectal cancer. Curr Probl Surg. 1997; 34:601-76.
9. Benson AB, Schrag D, Somefield MR, Cohen AM, Figueredo AT, Flynn PJ, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22:3408-19.
10. Herr HW, Bochner BH, Dalbagni G, Donat SM, Reuter VE, Bajorin DF. Impact of the number of lymph nodes on outcome in patients with muscle invasive bladder cancer. J Urol. 2002;167:1295-8.
11. Wilking N, Rutquist LE, Cartensen J, Mattsson A, Skoog L. Prognostic significance of axillary nodal status in primary breast cancer in relation to the number of resected nodes, Acta Oncol. 1992;31:25-9.
12. Gajra A, Newman N, Gamble GP, Kohman LJ, Graziano SL. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer. J Clin Oncol. 2003;21:1029-34.
13. Caplin S, Cerottini JP, Bosman FT, Constanda MT, Givel JC. For patients with Dukes' B (TNM stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis. Cancer. 1998;83:666-72.
14. Burdy G, Panis Y, Alves A, Nemeth J, Lavergne-Slove A, Valleur P. Identifying patients with T3-T4 node negative colon cancer at high risk of recurrence. Dis Colon Rectum. 2001;44:1682-8.
15. Wong JA, Bowles BJ, Bueno R, Shimizu D. Impact of the number of negative nodes on disease free survival in colorectal cancer patients. Dis Colon Rectum. 2002;45:1341-8.
16. Prandi M, Lionetto R, Bini A, Francioni G, Accarpio G, Anfossi A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy. Results of a secondary analysis of a large scale adjuvant trial. Ann Surg. 2002;235:458-63.
17. Joseph NE, Sigurdson ER, Hanlon AL, Wang H, Mayer RJ, MacDonald JS, et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection, Ann Surg Oncol. 2003;10:213-8.
18. Law CHL, Wright FC, Rapanos T, Alzahrani M, Hanna S, Khalifa M, et al. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer. J Surg Oncol. 2003;84: 120-6.
19. Le Voyer TE, Sigurdson ER, Hanlon AL, Mayer RJ, Macdonald JS, Catalano PJ, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089, J Clin Oncol. 2003;21:2912-9.
20. Berberoglu U. Prognostic significance of total lymph node number in patients with T1-4 NO MO colorectal cancer. Hepatogastroenterology, 2004;51:1689-93.
21. Adell-Carceller R, Segarra-Soria MA, Pellicer-Castell V, MarcoteValdivieso E, Gamón-Giner R, Bayón-Lara AM, et al. Impacto del número de ganglios negativos examinados en la evolución de los pacientes con cáncer colorrectal. Cir Esp. 2004;76:16-9.
22. Jestin P, Påhlman L, Glimelius B, Gunnarsson U. Cancer staging and survival in colon cancer is dependent on the quality of the pathologists' specimen examination Eur J Cancer. 2005;41:2071-8.
23. Cserni G, Vinh-Hung V, Burzykowski T. Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol. 2002;81:63-9.
24. Swanson RS, Compton CC, Stewart AK, Bland Kl. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65-71.
25. Sarli L, Bader G, Iusco D, Salvemini C, Di Mauro D, Mazzeo A, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer. 2005;41:272-9.
26. Johnson PM, Porter GA, Ricciardi R, Baxter NN, Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006;24:3570-5.
27. Berger AC, Sigurdson ER, Le Voyer T, Hanlon A, Mayer RJ, Macdonald JS, et al. Colon cancer survival is associated with decreasing ratio of metastatic to examined lymph nodes J Clin Oncol. 2005;23: 8706-12.
28. Dorrance HR, Docherty GM, O'Dwyer PJ, Effect of surgeon specialty interest on patient outcome after potentially curative colorectal cancer surgery Dis Colon Rectum. 2000;43:492-8.
29. Johnson PM, Malatjalim D, Parker G. Adequacy of nodal harvest in colorectal cancer. A consecutive cohort study. J Gastrointest Surg. 2002;6:883-90.
30. Bui L, Rempel E, Reeson D, Simunovic M. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: A population-based study. J Surg Oncol. 2006;93:439-45.
31. Miller EA, Woosley J, Martin CF, Sandler RS, Hospital-to-hospital variation in lymph nodes detection after colorectal resection. Cancer. 2004;101:1065-71.
32. Pheby DFH, Levine DF, Pitcher RW, Shepherd NA. Lymph node harvest directly influence the staging of colorectal cancer: evidence from a regional audit. J Clin Pathol. 2004;57:43-7.
33. Mönig SP, Baldus SE, Zirbes TK, Schöder W, Lindemann DG, Dienes HR et al. Lymph node size and metastatic infiltration in colon cacner. Ann Surg Oncol. 1999;6:579-81.
34. Pagès F, Berger A, Camus M, Sánchez-Cabo F, Costes A, Molidor R, et al. Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005;353:2654-66.
35. Compton CC. Updated protocol for the examination of specimens from patients with carcinomas of the colon and rectum, excluding carcinoid tumors, lymphomas, sarcomas, and tumors of the vermiform appendix, A basis for checklists, Arch Pathol Lab Med. 2000; 124:1017-25.
36. Herrera-Ornelas L, Justiniano J, Castillo N, Petrelli NJ, Stulc JR Mittelman A. Metastases in small lymph nodes from colon cancer. Arch Surg. 1987;122:1253-6.
37. Scott KWM, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance, Br J Surg. 1989; 76:1165-7.
38. Wong JH, Severino R, Honnebier MB, Tom R Namiki TS, Number of nodes examined on staging accurancy in colorectal carcinoma, J Clin Oncol. 1999;17:2896-900.
39. Wright FC, Law CHL, Last L, Khalifa M, Arnaout A, Naseer Z, et al. Lymph node retrieval and assessment in stage II colorectal cancer. A population-based study. Ann Surg Oncol. 2003;10:903-9.
40. Schofield JB, Mounter NA, Mallet R, Habouibi NY The importance of accurate pathological assessment of node involvement in colorectal cancer. Colorectal Disease. 2006;8:460-70.
41. Luna-Pérez R Rodríguez-Ramírez S, Alvarado I, Gutiérrez de la Barrera M, Labastida S, Prognostic significance of retrieval lymph nodes per specimen in resected rectal adenocarcinoma after chemoradiation therapy. Arch Med Res. 2003;34:281-6.
42. The Association of Coloproctology of Great Britain and Ireland. Report of the APCGBI Bowel cancer study. 2004;6:50-8.
43. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97:219-25.
44. Hernanz F, Revuelta S, Redondo C, Madrazo C, Castillo J, Gómez-Fleitas M. Colorectal adenocarcinoma: quality of the assessment of lymph node metastases, Dis Colon Rectum. 1994;37:373-7.
45. Leibl S, Tsybrovskyy O, Denk H. How many lymph nodes are necessary to stage and advancer adenocarcinoma of the sigmoid colon and upper rectum? Virchow Arch. 2003;443:133-8.
46. Horzic M, Kopljar M. Minimal number of lymph nodes that need to be examined for adequate staging colorectal cancer-factors influencing lymph node harvest, Hepatogastroenterology, 2005;52:86-9.
47. Görög D, Nagy R Péter A, Perner F. Influence of obesity on lymph node recovery from rectal resection specimens, Path Oncol Res. 2003;9:180-3.
48. Fleshman JW. The effect of the surgeon and the pathologist on patient survival after resection of colon and rectal cancer. Ann Surg. 2002;235:464-5.
49. Reinbach DH, McGregor JR, Murray GD, O'Dwyer PJ. Effect of the surgeon's specialty on the type of resection performed for colorectal cancer. Dis Colon Rectum. 1994;37:1020-3.
50. McArdle CS, Hole DJ. Influence of volume and specialization on survival following surgery for colorectal cancer. Br J Surg. 2004;91: 610-7.
51. Harmon JW, Tang DG, Gordon TA, Bowman HM, Choti MA, Kaufman HS, et al. Hospital volume can serve as a surrogate for surgeon volume for achieving excellent outcomes in colorectal resection. Ann Surg. 1999;230:404-11.
52. Parry JM, Collins S, Mathers J, Scott NA, Woodman CBJ. Influence of volume of work on the outcome of treatment for patients with colorectal cacner. Br J Surg. 1999;86:475-81.
53. Smith JAE, King PM, Lane RHS, Thomson MR. Evidence of the effect of "specialization" on the management, surgical outcome and survival from colorectal cancer in Wessex. Br J Surg. 2003;90:583-92.
54. Mella J, Biffin A, Radcliffe AG, Stamatakis ID, Steele RJ. Population-based audit of colorectal cancer management in two UK heath regions, Colorectal Cancer Working Group, Royal Colege of Surgeons of England, Clinical Epidemiology and audit Unit. Br J Surg. 1997;84:1731-6.
55. Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal specimens for adenocarcinoma, Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol. 1996;106:209-16.
56. Brown HG, Luckasevic TM, Medich DS, Celebrezze, Jones SM. Efficacy of manual dissection of lymph nodes in colon cancer resection. Mod Pathol. 2004;17:402-6.
57. Rodriguez-Bigas MA, Maamoun S, Weber TK, Penetrante RB, Blumenson LE, Petrelli NJ. Clinical significance of colorectal cancer: metastases in lymph nodes < 5mm in size, Ann Surg Oncol. 1996; 3:124-30.
58. Wei JT, Miller EA, Woosley JT, Martin CF, Sandler RS. Quality of colon carcinoma reporting: a process of care study. Cancer. 2004; 100: 1262-7.
59. Royal College of Pathologists Working Group on Cancer Services. Standards and minimum datasets for reporting common cancers. Minimum for colorectal cancer histopathology reports. London: The Royal College of Pathologists; 1998.
60. Haboubi NY, Abdalla SA, Amini S, Clark R Dougal M, Dube A, et al. The novel combination of fat clearance and inmunohistochemistry improves prediction of the outcome of patients with colorectal carcinomas: a preliminary study. Int J Colorectal Dis. 1998;13:99-102.
61. Haboubi NY, Clarck P, Kaflan SM, Schofield PF. The importance of combining xylene clearance and inmunohistochemistry in accurate staging of colorectal carcinoma, J R Soc Med. 1992;85:386-8.
62. Scott KW, Grace RH, Gibbons P. Five years follow-up study of the fat clearance technique in colorectal carcinoma, Dis Colon Rectum. 1994;37:126-8.
63. Greco R Andreola S, Magro G, Belli F, Giannone G, Gallino GF, et al. Potential pathological understaging of pT3 rectal cancer with less than 26 lymph nodes recovered: a prospective study based on resampling of 50 rectal specimens. Virchows Arch. 2006;449:647-51.
64. Mainprize KS, Hewavisinthe J, Savage A, Mortensen N, Warren BF. How many lymph nodes to stage colorectal carcinomas? J Clin Pathol. 1998;51:165-6.
65. Cianchi F, Palomba A, Boddi V, Messerini L, Pucciani F, Perigli G, et al. Lymph node recovery from colorectal tumor specimen: recommendation for a minimum number of lymph nodes to be examined. World J Surg. 2002;26:384-9.
66. Cserni G. The influence of nodal size on the staging of colorectal carcinomas. J Clin Pathol. 2002;55:386-90.
67. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal specimens spanning 45 years, Recommendations for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol. 2002;26:179-89.
68. Hermanek R [Oncologic surgery/pathologic-anatomic viewpoint]. Langenbecks Arch Chir Suppl Kongessbd. 1991;277-281.
69. Frankel K. Minimum number of lymph nodes to be recovered from colorectal resection specimens. Am J Clin Pathol. 1997;107:494.
70. Bush ST. Minimum number of lymph nodes to be recovered from colorectal resection specimens, Am J Clin Pathol. 1997;107:494.
71. Gumus M, Yumuk PF, Atalay G, Aliustaoglu M, Macunluoglu B, Dane F, et al. What is the optimal number of lymph nodes to be dissected in colorectal cancer surgery? Tumori. 2005;91:168-72.
72. Yoshimatsu K, Ishibashi K, Umehara A, Yokomizo H, Yoshida K, FujimotoT, et al. How many Iymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate. Hepatogastroenterology, 2005;52:1703-6.
73. Jha MK, Corbett WA, Wilson RG, Koreli A, Papagrigoriadis S. Variance of surgeon versus pathologists in staging colorectal cancer. Minerva Chir. 2006;61:385-91.
74. Turner J, Vollmer RT. Lymph nodes in colorectal carcinoma. The Poisson probability paradigm. Am J Clin Pathol. 2006;125:866-72.
75. Kim J, Huynh R, Abraham I, Kim E, Kumar RR. Number of lymph nodes and its impact on colorectal cancer staging. The American Surgeon. 2006;72:902-5.
76. Michiels C, Boutron MC, Chatelain N, Quipourt V, Roy R Faiver J. Facteurs prognostiques des adenocarcinomes colorectaux de stade B de Dukes. Etude d'une serve de population. Gastroenterol Clin Biol. 1994;18:456-61.
77. Maurel J, Launoy G, Grosclaude R Gignoux M, Arveux R MathieuDaudé H, et al. Lymph node harvest reporting in patients with carcinoma of the large bowel. A French population-based study. Cancer. 1998;82:1482-6.
78. Tepper JE, O'Connell MJ, Niedzwiecki D, Hollis D, Compton CC, Benson AB, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol. 2001;19:157-63.
79. Carloss H, Huang B, Cohen A, Carloss E, Wyatt S, Tucker T. The impact of number of lymph nodes removed on five-years survival in stage II colon and rectal cancer. J Ky Med Assoc. 2004;102: 345-7.
80. Fielding LP, Arsenault PA, Chapuis PM, Dent O, Gathright B, Hardcastle JD, et al. Clinicopathological staging for colorectal cancer: an international documentation system (IDS) and an international comprehensive anatomical therminology (ICAT), J Gastroenterol Hepatol. 1991;6:325-44.
81. a ed. New York: Springer; 2002.
82. Nelson H, Petrelli N, Carlin A, Couture J, Fleshman J, Guillem J, et al. Guidelines 2000 for colon and rectal cancer surgery, J Nat Cancer Ins. 2001;93:583-96.
83. Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, et al. Prognostic factors in colorectal cancer. College of American Pathologists consensus statement. Arch Pathol Lab Med. 2000;124:979-94.
84. Lledó-Matoses S, editor, Guías clínicas de la Asociación Española de Cirujanos. Cirugía colorrectal. Madrid: Aran Ediciones; 2000.